Resurrect Bio
PrivateLast Round
Series A
Feb 17, 2026
Total Funding Raised
$20.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Resurrect Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in February 2026.
Resurrect Bio is an agricultural biotechnology company that develops disease-resistant crops by utilizing AI-driven trait discovery and gene-editing technology to restore plant immune systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resurrect Bio Comparables
Compare Resurrect Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phytoform Labs | 89% | |
| Qi Biodesign | 82% | |
| Plantik Biosciences | 82% |
For institutional investors. Book with your work email.
Resurrect Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 17, 2026 | ||||
| Series A | Feb 17, 2026 | ||||
| Seed | May 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Resurrect Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Series A, Seed |
| SHAKE Climate Change Accelerator | Seed |
| Pymwymic | Series A |
| SynBioVen | Series A, Seed |
| UK Innovation & Science Seed Fund | Series A |
| Calculus Capital | Series A |
| AgFunder | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2026
Grew 33% QoQ, from 18 to 24 employees.
- Sep 12, 2026
Monthly visitors grew 49% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Resurrect Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Resurrect Bio's valuation, stock price, and market status.
Is Resurrect Bio a public or private company?
Resurrect Bio is a private company.
What is the current stock price of Resurrect Bio?
Resurrect Bio is a private company, so its shares have no public market price. Caplight tracks Resurrect Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Resurrect Bio worth (valuation)?
Valuation information for Resurrect Bio is not publicly available.
Can I buy Resurrect Bio stock?
Resurrect Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Resurrect Bio's last funding round?
Resurrect Bio's most recent funding round was Series A on February 17, 2026.
Who are the main investors in Resurrect Bio?
Key investors in Resurrect Bio include SynBioVen.
Will Resurrect Bio IPO soon?
No public IPO plans have been announced for Resurrect Bio.
How can I track Resurrect Bio secondary market activity?
Caplight tracks bids, offers, and trades in Resurrect Bio's shares on secondary markets.